Live feed
Filing
SC 13D
SC 13D0001493152-21-004039·Landos Biopharma, Inc.
Schedule 13D ownership disclosure
Landos Biopharma, Inc.
Security class unavailable · CUSIP: 515069102
Event date: 2021-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-21-004039
- Form type
- SC 13D
- Filer
- Landos Biopharma, Inc.
- CIK
- CIK 1785345
- Filed
- Feb 16, 2021
- Reporting period
- Feb 04, 2021
- Description
- Schedule 13D beneficial ownership